التخطي إلى المحتوى
✔ تجربة لمدة 60 يومًا  ✔ ضمان لمدة سنتين
تسجيل الدخول

البلد

اللغة

سلة المشتريات

سلة مشترياتك فارغة

Low-level light therapy of the eye and brain

Low-level light therapy of the eye and brain

Low-level light therapy (LLLT) using red to near-infrared light energy has gained attention in recent years as a new scientific approach with therapeutic applications in ophthalmology, neurology, and psychiatry. The ongoing therapeutic revolution spearheaded by LLLT is largely propelled by progress in the basic science fields of photobiology and bioenergetics. This paper describes the mechanisms of action of LLLT at the molecular, cellular, and nervous tissue levels. Photoneuromodulation of cytochrome oxidase activity is the most important primary mechanism of action of LLLT. Cytochrome oxidase is the primary photoacceptor of light in the red to near-infrared region of the electromagnetic spectrum. It is also a key mitochondrial enzyme for cellular bioenergetics, especially for nerve cells in the retina and the brain. Evidence shows that LLLT can secondarily enhance neural metabolism by regulating mitochondrial function, intraneuronal signaling systems, and redox states

Woman in black reclining on a cream chair

Not sure where to start?

Take our skin quiz to find your perfect routine

Find Your Routine